What is Rein Therapeutics, Inc. Common Stock's Market Cap?

Rein Therapeutics, Inc. Common Stock's Market Cap is $74.4M, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's Enterprise Value?

Rein Therapeutics, Inc. Common Stock's Enterprise Value is $78.8M, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's EV / EBITDA?

Rein Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's Revenue (TTM)?

Rein Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's Net Income (TTM)?

Rein Therapeutics, Inc. Common Stock's Net Income (TTM) is -$49.8M, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's EBITDA?

Rein Therapeutics, Inc. Common Stock's EBITDA is -$49.5M, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?

Rein Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.58, based on as-reported figures from SEC (XBRL) filings.

What is Rein Therapeutics, Inc. Common Stock's Net Debt?

Rein Therapeutics, Inc. Common Stock's Net Debt is -$40.6M, based on as-reported figures from SEC (XBRL) filings.

Rein Therapeutics, Inc. Common Stock (RNTX) Financial Statements

Rein Therapeutics, Inc. Common Stock

SIC 2834 · PHARMACEUTICAL PREPARATIONS

FIGI BBG002454KS0

XNAS · usd

0.86▼ 0.03 (-2.99%)

As of 2026-09-08

Valuation

Market Cap

Enterprise Value

Trailing P/E—

Price / Sales—

EV / Revenue—

EV / EBITDA

Financial Highlights

Revenue (TTM)

Net Income (TTM)

EBITDA

Diluted EPS (TTM)

EBITDA Margin—

Net Debt

Trading Information

Previous Close0.89

Day's Range0.85 – 0.96

52-Week Range0.69 – 2.18

Volume757.1K

Avg Volume476.5K

Share Statistics

Shares Outstanding

Employees10

ExchangeXNAS

Listed2017-06-29

Share count as of August 12, 2026

ViewDetail

Period

Loading Income Statement…

Key questions about Rein Therapeutics, Inc. Common Stock (RNTX)

What is Rein Therapeutics, Inc. Common Stock's Market Cap?: Rein Therapeutics, Inc. Common Stock's Market Cap is $74.4M, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's Enterprise Value?: Rein Therapeutics, Inc. Common Stock's Enterprise Value is $78.8M, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's EV / EBITDA?: Rein Therapeutics, Inc. Common Stock's EV / EBITDA is n/m, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's Revenue (TTM)?: Rein Therapeutics, Inc. Common Stock's Revenue (TTM) is $0.00, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's Net Income (TTM)?: Rein Therapeutics, Inc. Common Stock's Net Income (TTM) is -$49.8M, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's EBITDA?: Rein Therapeutics, Inc. Common Stock's EBITDA is -$49.5M, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's Diluted EPS (TTM)?: Rein Therapeutics, Inc. Common Stock's Diluted EPS (TTM) is -0.58, based on as-reported figures from SEC (XBRL) filings.
What is Rein Therapeutics, Inc. Common Stock's Net Debt?: Rein Therapeutics, Inc. Common Stock's Net Debt is -$40.6M, based on as-reported figures from SEC (XBRL) filings.